Nuclear Medicine: Page 158

Start-up Brain Biosciences advances compact PET scanner

By Wayne Forrest

Start-up firm Brain Biosciences is hoping to ride the wave of interest in PET scanning for Alzheimer's and other brain diseases by commercializing CerePET, a portable PET scanner designed to offer more cost-effective neuroimaging than whole-body scanners.

January 22, 2014

PET/CT predicts colon cancer response

By AuntMinnie.com staff writers

A Danish study published online January 22 in the Oncologist shows that PET/CT and biomarkers can help clinicians predict treatment response in patients with metastatic colon cancer.

January 21, 2014

Software adds diagnostic value for heart disease patients

By Wayne Forrest

Dutch researchers have developed 3D visualization software that fuses anatomical and functional data into a single image. They believe the fused images make it easier to diagnose cases of coronary artery disease, according to a paper in the January issue of the Journal of Nuclear Medicine.

January 20, 2014

FDM shows promise as cardiac PET tracer

By AuntMinnie.com staff writers

Researchers from Mount Sinai Hospital are testing a new sugar-based radiotracer known as fluorodeoxymannose (FDM) as a cardiovascular PET imaging agent.

January 13, 2014

Nordion revenue declines in fiscal 2013

By AuntMinnie.com staff writers

Canadian radioisotope firm Nordion has posted lower revenue for its 2013 fiscal year.

January 8, 2014

PET with F-18 FDOPA differentiates brain lesions

By Wayne Forrest

PET with the radiopharmaceutical fluorine-18 fluorodopa (F-18 FDOPA) can help differentiate recurrent or progressive brain metastases from late or delayed radiation injury, according to a study published in the January issue of the Journal of Nuclear Medicine.

January 8, 2014